A Swedish-based nonprofit research organization published a report exposing the involvement of Western companies in the organ harvesting industry in China, Vision Times has learned.
The report entitled Economics Of Organ Harvesting In China was carried out by the Institute to Research the Crimes of Communism. The list includes twenty global companies raging from pharmaceuticals to medical equipment with some big names such as Roche (Switzerland), Pfizer (USA), Sanofi (France) among others.
Insights from the report
The report points out how China depends on those suppliers in the development of its lucrative organ harvesting practice by citing the paper of The Swedish Trade and Investment Council, Business Sweden, which stated that up to 92% of the medical technology devices for transplantation in China come from foreign companies.
The two authors delved into the connection between those 20 companies and the Chinese transplant industry by looking into stock market reports indicating the revenue/profit that they have generated in the Chinese market, and the presence of their products in the Chinese medical study.
For example, evidence shows that when it comes to immunosuppressive drugs (a class of drugs that suppress, or reduce, the strength of the body’s immune system), one-third of the revenue of Pfizer’s product Rapamune was generated in China. China is also Pfizer’s biggest market, experiencing a steady increase over the year.
The paper summed up that the potential profit for Western companies for every transplant procedure in China would amount to 71% of the cost given the fact that a kidney transplant in China costs US$10,531 by the hospital, “where 69.2% makes up the medications and 2% miscellaneous medical services.”
It came to the conclusion that those companies “are not only supporting such transplant business in China, but also have enabled it to get to a massive scale.”
Despite abundant evidence of the Western countries’ participation in the atrocities of organ harvesting in China, whether knowingly or not, the paper failed to make it clear, claiming that further investigation into it is required.
Yet, it commented that given the crucial role of those key players, the process of illegal organ harvesting from prisoners of conscience could be restrained or even be completely stopped, only if these companies were to cease supplying their products to the Chinese market.
Feedback from international communities
Since its debut in November 2019, the paper has gained considerable attention from the international community.
Susie Hughes, executive director of the International Coalition to End Transplant Abuse in China (ETAC), stated, “These companies are in a very powerful position because China’s transplant industry would falter without them. It is imperative they withdraw from China immediately to help save innocent people who are being killed for their organs.”
Hamid Sabi, counsel to the China Tribunal, who recently raised the issue of forced organ harvesting in China for the first time at the United Nations said, “I welcome all new research confirming this horrifying issue. Organ transplantation to save life is a scientific and social triumph but killing the donor is criminal.”
David Matas, international human rights lawyer and expert witness who testified at the China Tribunal said, “The report sets out compelling evidence that several multinational companies are complicit in transplant abuse in China where prisoners of conscience are killed for their organs. This complicity violates the Organization for Economic Cooperation and Development Guidelines for Multinational Enterprises. The national contact points responsible for the Guidelines should be engaged in each of the countries where these countries are headquartered to address this complicity.”
Efforts to expose the atrocity of organ harvesting in China
There have been efforts to expose the atrocity of organ harvesting in China over the years.
In the 2016 report “Bloody Harvest/The Slaughter: An Update” David Kilgour, Matas, and Ethan Gutmann, all three Nobel Peace Prize nominees exposed the practice of state-sanctioned organ harvesting from nonconsenting prisoners of conscience including from large numbers of Falun Gong practitioners and members of other religious and ethnic minority groups in China.
The same conclusion was made by Edward McMillan Scott, European Parliament vice president from 2004 to 2014.
“The organ transplant industry is in the hands of the military,” McMillan Scott said on the 2010 European Parliament Transplant Plenary. “The People’s Liberation Army is responsible for the hospitals, the transportation of body parts, and the sale of them. It is therefore a governmental activity, and constitutes genocide under Article 2 of the Genocide Convention.”
“The China Tribunal, initiated by the International Coalition to End Transplant Abuse in China (ETAC), an independent, international people’s tribunal that, after assessing all available evidence over the course of 12 months, unanimously concluded, “Commission of Crimes Against Humanity against the Falun Gong and Uighurs has been proved beyond reasonable doubt,” in the hearing in 2018.